Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Krankenberg H, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116(3):285–92.
Tepe G, et al. Drug-Coated Balloon versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and/or Popliteal Peripheral Artery Disease: 12-Month Results from the IN.PACT SFA Randomized Trial. Circulation. 2015;131(5):495–502.
Rosenfield K, for the LEVANT 2 Investigators, et al. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. N Engl J Med. 2015;373:145–53.
Tepe G. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv. 2015;8(1 Pt A):102–8.
Tepe G, et al. High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study. J Endovasc Ther. 2013;20(6):792–800.
Coronary Artery angiographic changes after PTCA: Manual of Operations NHBLI PTCA Registry 1985-6:9.
Adlakha S, et al. Stent fracture in the coronary and peripheral arteries. J Interv Cardiol. 2010;23:411–9.
Iida O, et al. Effect of exercise on frequency of stent fracture in the superficial femoral artery. Am J Cardiol. 2006;98:272–4.
Scheinert D, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45(2):312–5.
Laird JR, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267–76.
Davaine JM, et al. One-year clinical outcome after primary stenting for trans-atlantic inter-society consensus (TASC) C and D femoropopliteal lesions (the STELLA “stenting long de l’artere femorale superficielle” cohort). Eur J Vasc Endovasc Surg. 2012;44:432–41.
Bosiers M, et al. Zilver PTX Single-Arm Study Investigators. The Zilver® PTX® Single Arm Study: 12-month results from the TASC C/D lesion subgroup. J Cardiovasc Surg. 2013;54(1):115–22.
Werner M, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention. 2014;10(7):861–8.
Lin Y, et al. Stent fractures after superficial femoral artery stenting: risk factors and impact on patency. J Endovasc Ther. 2015;22(3):319–26.
Antoniou GA, et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease. J Vasc Surg. 2013;57(1):242–53.
Pereira CE, et al. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg. 2006;44(3):510–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Attaran, R.R., Mena-Hurtado, C.I. (2018). Endovascular Management of Lower Limb Claudication due to Infra-Inguinal Disease. In: Geroulakos, G., Sumpio, B. (eds) Vascular Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-65936-7_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-65936-7_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65935-0
Online ISBN: 978-3-319-65936-7
eBook Packages: MedicineMedicine (R0)